Your browser doesn't support javascript.
loading
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
Santos, Raul D; Gidding, Samuel S; Hegele, Robert A; Cuchel, Marina A; Barter, Philip J; Watts, Gerald F; Baum, Seth J; Catapano, Alberico L; Chapman, M John; Defesche, Joep C; Folco, Emanuela; Freiberger, Tomas; Genest, Jacques; Hovingh, G Kees; Harada-Shiba, Mariko; Humphries, Steve E; Jackson, Ann S; Mata, Pedro; Moriarty, Patrick M; Raal, Frederick J; Al-Rasadi, Khalid; Ray, Kausik K; Reiner, Zelijko; Sijbrands, Eric J G; Yamashita, Shizuya.
Afiliación
  • Santos RD; Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital, and Preventive Medicine Centre and Cardiology Program, Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: rdsf@uol.com.br.
  • Gidding SS; Nemours Cardiac Center, A I DuPont Hospital for Children, Wilmington, DE, USA.
  • Hegele RA; Department of Medicine and Robarts Research Institute, Schulich School of Medicine, Western University, London, ON, Canada.
  • Cuchel MA; Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Barter PJ; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Watts GF; Lipid Disorders Clinic, Royal Perth Hospital, The University of Western Australia, Perth, WA, Australia.
  • Baum SJ; Preventive Cardiology, Christine E Lynn Women's Health & Wellness Institute, Boca Raton Regional Hospital, Boca Raton, FL, USA.
  • Catapano AL; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy; IRCCS Multimedica, Milan, Italy.
  • Chapman MJ; Pitié-Sâlpetrière University Hospital, Paris, France.
  • Defesche JC; University of Amsterdam, Academic Medical Center (AMC), Amsterdam, Netherlands.
  • Folco E; International Atherosclerosis Society, Milan, Italy.
  • Freiberger T; Molecular Genetics Lab, Centre for Cardiovascular Surgery and Transplantation, and Ceitec, Masaryk University, Brno, Czech Republic.
  • Genest J; McGill University Health Center, Royal Victoria Hospital, Montreal, QC, Canada.
  • Hovingh GK; University of Amsterdam, Academic Medical Center (AMC), Amsterdam, Netherlands.
  • Harada-Shiba M; National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
  • Humphries SE; Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, University College of London, London, UK.
  • Jackson AS; International Atherosclerosis Society, Houston, TX, USA.
  • Mata P; Fundación Hipercolesterolemia Familiar, Madrid, Spain.
  • Moriarty PM; Atherosclerosis and Lipoprotein-Apheresis Center, University of Kansas Medical Center, Kansas City, KS, USA.
  • Raal FJ; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Al-Rasadi K; Sultan Qaboos University Hospital, Muscat, Oman.
  • Ray KK; School of Public Health, Imperial College London, London, UK.
  • Reiner Z; European Association for Cardiovascular Prevention and Rehabilitations, Zagreb, Croatia.
  • Sijbrands EJ; Department of Internal Medicine, Erasmus MC, Rotterdam, Netherlands.
  • Yamashita S; Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Lancet Diabetes Endocrinol ; 4(10): 850-61, 2016 10.
Article en En | MEDLINE | ID: mdl-27246162

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Hiperlipoproteinemia Tipo II Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Hiperlipoproteinemia Tipo II Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido